FDA applicant
G21, S.R.L.
FDA records 12 decisions for G21, S.R.L. (San Possidonio, IT) from 2015 to 2025: 12 510(k) clearances. Most are in product codes MBB (Bone Cement, Antibiotic) and LOD (Bone Cement). Since 2016 its 510(k)s took a median of 154 days from receipt to decision, against 139 for FDA’s reviews in the same codes and years. Its devices cite 26 predicates, 4 of them its own earlier devices. No recall is linked to its devices.
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) refreshed weekly
How often FDA has decided G21, S.R.L.’s devices, and how often a recall has named them.
FDA decisions per year
1in 2025
2026 so far, outlined.
Recalls per year
No recall linked to its devices since 2015.
Planning a device like G21, S.R.L.’s? A 510(k) Report ranks candidate predicates for your device by lineage, citations and recall history, with the review-time outlook.
See the 510(k) Report